Suzuki Hiroyuki

スズキヒロユキ | Suzuki Hiroyuki

Affiliation and department：

Research field (1)： Radiology

Research keywords (2)：分子イメージング , 放射性薬剤

Research theme for competitive and other funds (8)：

2022 - 2025 悪性黒色腫の標的α線治療を指向するAt-211標識薬剤開発
2023 - 2025 がんの標的アルファ線治療への応用を指向する生体内安定な211At標識法の開発
2023 - 2023 悪性黒色腫に対する標的α線治療の実現性を向上するAt-211標識基盤技術の改良
2019 - 2022 Development of At-211-labeled agents targeting the tumor hypoxia region
2018 - 2021 Development of a versatile alpha particle therapy using At-211 labeled amino acids with controlled pharmacokinetics

Show all

Papers (27)：

Hiroyuki Suzuki, kento kannaka, Tomoya Uehara. Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies. Pharmaceuticals. 2024
Hiroyuki Suzuki. Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics. EJNMMI Radiopharmacy and Chemistry. 2024
Hiroyuki Suzuki. Reduction of the Renal Radioactivity of ¹¹¹In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes. Journal of Medicinal Chemistry. 2023. 66. 13. 8600-8613
Hiroyuki Suzuki. Stability Estimation of Gallium Complexes of DOTA Derivatives for Radiotheranostic Applications. ACS Omega. 2022. 7. 47. 43321-43328
Hiroyuki Suzuki. Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides. Nuclear Medicine and Biology. 2022. 114-115. 18-28

ｍore...

Education (3)：

2010 - 2013 Chiba University Graduate School of Medical and Pharmaceutical Sciences
2008 - 2010 Chiba University Graduate School of Medical and Pharmaceutical Sciences
2004 - 2008 Chiba University Faculty of Pharmaceutical Sciences

Professional career (1)：

Work history (2)：

Awards (3)：

Association Membership(s) (3)：

日本分子イメージング学会 , 日本核医学会 , 日本薬学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page